Goldman Sachs Forecasts Strong Price Appreciation for Chemours Stock

Research analysts at The Goldman Sachs Group raise price target for the specialty chemicals company.

Published on Feb. 27, 2026

Got story updates? Submit your updates here. ›

Chemours (NYSE:CC) had its price objective increased by research analysts at The Goldman Sachs Group from $14.00 to $18.00 in a research report. The brokerage presently has a 'neutral' rating on the stock. The Goldman Sachs Group's new price target indicates a potential upside of 3.93% from the company's previous close.

Why it matters

This price target increase by a major investment bank like Goldman Sachs suggests that analysts see strong potential for Chemours' stock to appreciate in value in the near future. As a specialty chemicals company, Chemours' performance is closely watched by investors as an indicator of broader industry trends.

The details

The Goldman Sachs Group raised its price target on Chemours from $14.00 to $18.00, while maintaining a 'neutral' rating on the stock. Several other equity research analysts have also recently issued reports on Chemours, with some upgrading the stock to a 'buy' rating and increasing their price targets.

  • The Goldman Sachs Group issued the research report on Wednesday, February 27, 2026.

The players

The Goldman Sachs Group

A multinational investment bank and financial services company headquartered in New York City.

Chemours

A global chemistry company that focuses on delivering performance chemicals to help customers lower their carbon footprint, increase energy efficiency and conserve water.

Got photos? Submit your photos here. ›

What they’re saying

“Chemours (NYSE:CC – Get Free Report) had its price objective increased by research analysts at The Goldman Sachs Group from $14.00 to $18.00 in a research report issued to clients and investors on Wednesday.”

— The Goldman Sachs Group, Research Analysts (Benzinga)

The takeaway

The price target increase by Goldman Sachs suggests that the investment bank sees strong potential for Chemours' stock to appreciate in value, which could signal broader positive momentum in the specialty chemicals industry.